Prevalence and Prognostic Significance of 1p36 Microdeletions in Non-Hodgkin B Cell Lymphomas (B-NHL)

被引：0
|
作者：
Gru, A. [1 ]
Kreisel, F. [1 ]
Nguyen, T. [1 ]
Frater, J. L. [1 ]
Hassan, A. [1 ]
机构：
[1] Washington Univ, St Louis, MO USA
来源：
LABORATORY INVESTIGATION | 2010年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1338
引用
收藏
页码：299A / 299A
页数：1
相关论文
共 50 条
  • [31] Relationship between exposure and safety/efficacy of loncastuximab tesirine (Lonca) in B-cell non-Hodgkin lymphoma (B-NHL).
    Hess, Brian
    Ai, Weiyun
    Townsend, William
    Ungar, David
    Liao, Sam
    Liao, Lori
    Zhang, Xiaoyan
    Boni, Joseph
    CANCER RESEARCH, 2021, 81 (13)
  • [32] Flow Cytometry for B-Cell Non-Hodgkin and Hodgkin Lymphomas
    Gajzer, David C.
    Fromm, Jonathan R.
    CANCERS, 2025, 17 (05)
  • [33] Impact of Human Leukocyte Antigen (HLA) Alleles on Outcomes of Allogeneic Transplantation (Allo-HCT) for B-Cell Non-Hodgkin Lymphomas (B-NHL); A CIBMTR Analysis
    William, Basem M.
    Wang, Tao
    Haagenson, Michael D.
    de Lima, Marcos J.
    Fernandez-Vina, Marcelo Anibal
    Stephen, Spellman
    Lee, Stephanie J.
    Hill, Brian T.
    BLOOD, 2016, 128 (22)
  • [34] Phase I study of bendamustine combined with rituximab in relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (B-NHL)
    Taniwaki, M.
    Ogura, M.
    Matsumoto, Y.
    Uchida, T.
    Ohmachi, K.
    Ando, K.
    Watanabe, T.
    Tobinai, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [35] Phase II study of oral Fludarabine (FAMP) in combination with rituximab in indolent B-cell non-hodgkin lymphoma (B-NHL)
    Ishizawa, Kenichi
    Tobinai, Kensei
    Ogura, Michinori
    Itoh, Kuniaki
    Aorishima, Yasuo
    Ando, Kiyoshi
    Yamamoto, Joji
    Watanabe, Takashi
    Uchida, Toshiki
    Nakata, Masanobu
    Hayashi, Masaki
    Hotta, Tomomitsu
    BLOOD, 2007, 110 (11) : 387A - 387A
  • [36] Rearrangements of chromosome band 1p36 in non-Hodgkin's lymphoma
    Dave, BJ
    Hess, MM
    Pickering, DL
    Zaleski, DH
    Pfeifer, AL
    Weisenburger, DD
    Armitage, JO
    Sanger, WG
    CLINICAL CANCER RESEARCH, 1999, 5 (06) : 1401 - 1409
  • [37] The role of p18 in human B cells and B cell non-Hodgkin lymphomas.
    Ely, SA
    Knowles, DM
    Tan, LHC
    DeLiberto, M
    Chen-Kiang, S
    BLOOD, 2003, 102 (11) : 282B - 282B
  • [38] CYTOKINE EXPRESSION IN B-CELL NON-HODGKIN LYMPHOMAS
    MERZ, H
    FLIEDNER, A
    LEHRNBECHER, T
    SEBALD, W
    MULLERHERMELINK, HK
    FELLER, AC
    HEMATOLOGICAL ONCOLOGY, 1990, 8 (06) : 355 - 361
  • [39] Novel treatments in B cell non-Hodgkin's lymphomas
    Sawalha, Yazeed
    Maddocks, Kami
    BMJ-BRITISH MEDICAL JOURNAL, 2022, 377
  • [40] DP-1 expression in non-Hodgkin lymphomas (NHL)
    Chan, J
    Olvera, M
    Lai, R
    Naing, W
    Nathwani, B
    Brynes, RK
    LABORATORY INVESTIGATION, 2001, 81 (01) : 158A - 158A
12345